Kyndryl Stock Sinks After Short-Seller Alleges IBM Deal Masked Billions In Hidden Costs – But Retail Traders Aren’t Buying It
Short-seller Gotham City Research calls Kyndryl ‘uninvestable,’ raising concerns over its financial reporting, cash flows, and insider selling.